Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court Meghna A Singhania3 May 2019 1:50 PM ISTMumbai:In a court setback to many big drugmakers in India, a petition filed by pharma majors including Biocon, Wockhardt, Lupin and Cadila Healthcare...
Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India Farhat Nasim2 March 2019 11:00 AM IST"Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar...
Oops- Biocon chief fined Rs 9.5 lakh by Infosys Garima1 March 2019 5:51 PM ISTIn its filing, the company stated that such trade is a violation of the Company's Insider Trading Policy and the Sebi (Prohibition of Insider Trading)...
Launching product without Approval: DOP rejects Biocon Plea against NPPA action Meghna A Singhania24 Feb 2019 11:25 AM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
Biocon chief Kiran Shaw says it's a struggle to find adequate number of women for leadership roles Farhat Nasim23 Feb 2019 10:00 AM IST"Over the next five to ten years we will hopefully see many more women playing leadership roles. Yes, things are happening but not at the pace that I...
USFDA approves Mylan, Biocon's Fulphila, the first biosimilar to Neulasta Ruby Khatun Khatun6 Jun 2018 10:30 AM ISTHERTFORDSHIRE/PITTSBURGH and BENGALURU: Mylan N.V. and Biocon Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Mylan's...
Biocon sells 1.88 percent stake in Syngene for Rs 230 crore Ruby Khatun Khatun19 May 2018 11:00 AM ISTNew Delhi: Biocon Ltd has sold close to 2% stake in its research arm Syngene International for an estimated Rs230 crore."Biocon, the promoter of...
Biocon, Mylan get European Commission approval to market biosimilar insulin glargine Ruby Khatun Khatun30 March 2018 10:30 AM ISTNew Delhi: Biotechnology major Biocon and Mylan said their co-developed biosimilar insulin glargine has received marketing authorization approval from...
Roche plea in HC on cancer drug not maintainable: Biocon, Mylan Ruby Khatun Khatun12 Jan 2018 10:27 AM ISTNew Delhi: Generic drug makers Biocon and Mylan told the Delhi High Court that Swiss pharma major Roche's civil suit, challenging DCGI approvals...
EMA accepts marketing authorization applications of Mylan and Biocon for 2 biosimilars Ruby Khatun Khatun2 Dec 2017 10:00 AM ISTHERTFORDSHIRE, England, PITTSBURGH and BENGALURU: Mylan N.V. and Biocon Ltd. announced that the European Medicines Agency (EMA) has accepted for...
Biocon launches colon cancer drug in India, priced Rs 24,000 Ruby Khatun Khatun24 Nov 2017 10:01 AM ISTBengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...
UE LifeSciences in distribution partnership with GE Healthcare Ruby Khatun Khatun12 Nov 2017 10:15 AM ISTBengaluru: UE LifeSciences Inc, a USA-India based med-tech startup, announced a distribution partnership with GE Healthcare to commercialize its...
